NASDAQ:DFTX | Income Statement | Definium Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$48.67M$75.08M-$75.08M-$158.99M-$1.44-$1.44110,684,720110,684,720
2026-03-31$41.48M$59.22M-$59.22M-$77.1M-$0.71-$0.71108,790,941108,790,941
2025-12-31$33.52M$47.58M-$47.58M-$50.44M-$0.50-$0.503,890,9303,890,930
2025-09-30$30.98M$45.67M-$45.67M-$67.27M-$0.78-$0.7885,885,51685,885,516
2025-06-30$29.81M$40.9M-$40.9M-$42.74M-$0.50-$0.5085,347,67785,347,677
2025-03-31$23.36M$32.16M-$32.16M-$23.35M-$0.27-$0.3585,067,85587,091,461
2024-12-31$21.76M$32.46M-$32.46M-$34.74M-$0.42-$0.424,523,0424,523,042
2024-09-30$17.19M$24.79M-$24.79M-$13.68M-$0.18-$0.2777,909,44180,238,688
2024-06-30$14.65M$24.46M-$24.46M-$5.85M-$0.08-$0.2671,912,32375,304,101
2024-03-31$11.71M$22.2M-$22.2M-$54.4M-$1.14-$1.1447,860,75747,860,757
2023-12-31$11.55M$22.21M-$22.21M-$23.86M-$0.59-$0.59359,046359,046
2023-09-30$13.2M$21.62M-$21.62M-$17.92M-$0.45-$0.4539,720,00739,720,007
2023-06-30$14.78M$29.18M-$29.18M-$29.13M-$0.76-$0.7638,576,39438,576,394
2023-03-31$12.6M$20.86M-$20.86M-$24.82M-$0.65-$0.6538,077,25138,077,251
2022-12-31$8.83M$13.9M-$13.9M-$4.9M-$4.9M-$0.02-$0.022,291,3022,291,302
2022-09-30$7.77M$16.98M-$16.98M-$16.49M$0.00-$16.49M-$0.56-$0.5629,296,33329,296,333
2022-06-30$9.33M$16.94M-$16.94M-$16.96M$0.00-$16.96M-$0.60-$0.6028,242,02628,242,026
2022-03-31$10.24M$18.51M-$18.51M-$18.45M-$0.66-$0.6628,147,49928,147,499
2021-12-31$10.88M$17.56M-$17.56M-$17.99M-$1.16M-$16.83M-$0.59-$0.59252,785252,785
2021-09-30$9.02M$17.23M-$17.23M-$17.2M$0.00-$17.2M-$0.61-$0.6128,013,80928,013,809
2021-06-30$8.07M$45.22M-$45.22M-$45.25M$0.00-$45.25M-$0.11-$0.11410,823,106410,823,106
2021-03-31$6.81M$13.85M-$13.85M-$13.76M389,575,029

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$117.67M$166.31M-$166.31M-$183.79M$0.00-$183.79M-$2.06-$2.0689,327,60889,327,608
2024-12-31$65.3M$103.92M-$103.92M-$108.68M-$108.68M-$1.54-$1.5470,461,06770,461,067
2023-12-31$52.12M$93.87M-$93.87M-$95.73M-$95.73M-$2.44-$2.4439,157,42039,157,420
2022-12-31$36.17M$66.33M-$66.33M-$56.8M-$56.8M-$1.84-$1.8430,857,46330,857,463
2021-12-31$34.79M$93.85M-$93.85M-$94.19M-$1.16M-$93.04M-$3.40-$3.4027,377,08227,377,082
2020-12-31$18.63M$33.03M-$33.03M-$33.94M-$33.94M266,220,592
2019-12-31-$10.7M